Table 4. Treatment contact coverage for probable depressive disorder in PRIME implementation areas, 2013–2014.
| Characteristic (%, and 95% CI) | Sodo District, Ethiopia | Sehore District, India | Chitwan District, Nepal | Kamuli District, Uganda | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Men | Women | Total | Men | Women | Total | Men | Women | Total | Men | Women | ||
| PHQ9 positive (%) | 8.0b (6.6–9.6) | 5.9b (4.2–8.2) | 9.9b (7.9–12.5) | 17.7 (16.3–19.1) | 16.8 (15.1–18.6) | 18.7 (16.8–20.8) | 3.6 (2.8–4.6) | 3.6 (2.3–5.5) | 3.6 (2.7–4.7) | 6.5 (4.3–9.7) | 4.3 (2.7–6.7) | 7.8 (4.8–12.7) | |
| Recent (12 months) history of depressive symptoms (%) | 24.1 (21.8–26.6) | 22.9 (19.7–26.5) | 25.2 (22.0–28.7) | 23.5 (21.7–25.5) | 20.7 (18.5–23.2) | 26.9 (24.2–29.9) | 9.6 (8.2–11.3) | 8.1 (6.0–10.8) | 10.7 (8.7–13.0) | 22.7 (19.0–26.8) | 19.9 (15.4–25.3) | 26.3 (21.7–31.5) | |
| PHQ9-positive or recent history of depressive symptoms (%) | 25.3b (23.0–27.8) | 23.4b (20.1–27.0) | 27.2b (24.0–30.7) | 29.7 (27.9–31.6) | 26.3 (24.2–28.7) | 33.9 (31.0–36.7) | 11.2 (9.7–13.0) | 10.0 (7.7–12.8) | 12.1 (10.1–14.4) | 23.2 (19.5–27.4) | 20.7 (16.1–26.0) | 26.8 (22.1–31.9) | |
| Treatment contact coverage (of those who are PHQ9 positive or have recent history of depressive symptoms) (%) | 23.9ab (19.8–28.6) | 24.9ab (18.8–32.4) | 23.1ab (17.9–29.3) | 12.8 (10.5–15.6) | 12.3 (9.5–15.9) | 13.1 (9.8–17.3) | 8.1 (4.6–13.3) | 6.3 (2.6–14.5) | 9.1 (4.6–17.0) | 23.7 (17.7–31.1) | 22.5 (13.2–35.6) | 26.9 (20.6–34.3) | |
| Contact coverage from specialist health provider (%) | 0.2ab (0.0–1.3) | 0.4ab (0.05–2.9) | 0.0 | 3.0 (1.9–4.7) | 4.4 (2.6–7.2) | 1.8 (0.8–3.7) | 3.5 (1.7–6.8) | 4.5 (1.7–11.5) | 2.9 (1.2–7.0) | 2.4 (1.1–5.2) | 4.1 (1.3–12.5) | 0.2 (0.03–1.6) | |
| Contact coverage from generalist health provider (%) | 12.2ab (9.2–16.2) | 11.2ab (7.0–17.5) | 13.1ab (9.0–18.6) | 7.8 (6.0–10.2) | 6.6 (4.5–9.6) | 9.0 (6.5–12.4) | 1.7 (0.6–4.6) | 1.8 (0.3–12.0) | 1.6 (0.6–4.6) | 16.8 (12.4–22.3) | 14.6 (8.5–23.9) | 20.7 (15.0–27.9) | |
| Contact coverage from complementary provider (%) | 10.5ab (7.8–13.9) | 11.2ab (7.2–17.1) | 9.9ab (6.6–14.4) | 2.6 (1.8–3.8) | 1.9 (1.0–3.6) | 3.4 (2.1–5.3) | 4.0 (1.6–9.4) | 0.5 (0.07–3.7) | 6.0 (2.3–14.5) | 3.9 (1.8–8.6) | 3.8 (0.8–16.3) | 4.0 (2.0–7.7) | |
a Lifetime treatment contact coverage, rather than over the past 12 months.
b Using a PHQ-9 cut off score of ≥7.